ROG.SW
Roche Holding AG
Health Care · Pharmaceuticals · SIX Swiss Exchange
$322.30
Data: 2026-05-09
✓ ETHICAL PASS

Unknown MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$256.4B
Total market value of the company
20.11
Premium valuation
14.82
Based on estimated future earnings — lower means cheaper
Rev Growth
-0.4%
Year-over-year revenue change
Profit Margin
0.0%
How much profit the company keeps from each dollar of revenue
37.3%
Return on equity — how efficiently it uses shareholder money
Analyst Target
N/A
Recommendation
N/A
Consensus view from ? analysts covering this stock
About Roche Holding AG

Company description not available.

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
33.0% PASS
Debt must be below 33% of total assets
Cash Ratio
5.5% PASS
Interest-bearing cash below 33% of assets
Receivables
12.3% PASS
Receivables below 49% of assets
Revenue Purity
1.8% PASS
Non-compliant revenue below 5% — any excess requires purification
Valuation
$115.88
What our model estimates this business is worth per share
-178.1%
Trading above fair value — no margin of safety
Rating
FAIR VALUE
Overall assessment combining ethics, valuation, and quality
94.3th
Ranks in the top 6% of our 13,571 screened universe
Ethical Score
77.9
Valuation Score
65.5
Quality Score
52.0
Combined
N/A

Trading at $322, 178% above fair value of $116. Passes all ethical screens. Ranks better than 88% of screened stocks.

Market Data

Trading characteristics and market positioning

N/A
52W High
$N/A
52W Low
$N/A
Avg Volume
N/A
Average daily shares traded — higher means easier to buy and sell
N/A
Days it would take all short sellers to cover — higher means more crowded
Short % Float
N/A
3.0%
Annual dividend as a percentage of the share price
$16.03
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

87.64
Heavy leverage — higher financial risk if revenues decline
Quick Ratio
N/A
Like current ratio but excludes inventory — stricter test
Gross Margin
N/A
Revenue left after cost of goods — higher means pricing power
Operating Margin
N/A
Profit from core operations before interest and tax
N/A
Negative — the business is spending more than it generates
Revenue (TTM)
N/A
Total revenue over the last 12 months
Net Income
N/A
Loss-making — spending exceeds revenue after all costs
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-09

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.